IPV Vaccines Market, by Vaccine Brand, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2025

Description

Global Ipv Vaccines Market is estimated to be valued at USD 199.9 Mn in 2025 and is expected to reach USD 358.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 199.9 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.70%	2032 Value Projection:	USD 358.5 Mn

Figure. Ipv Vaccines Market Share (%), By Region 2025

Inactivated polio vaccine (IPV) is also known as Salk vaccine. For the vaccination against polio there are two vaccines available: inactivated polio vaccine and oral polio vaccine. The IPV vaccine is mostly given in arm or leg as a shot.

Individuals who are allergic to eggs or the drugs such as streptomycin should not receive the injectable IPV. The IPV is only given if the vaccine recipient is on steroid therapy for long-term, has cancer, or is on ongoing process of chemotherapy or there is any unimmunized adult in house.

Global IPV vaccines market was valued at USD 199.9 Mn in 2025 and is expected to increase to US$ 358.5 Mn by 2032, registering a CAGR of 8.7% over the forecast period.

Market Dynamics

Various governments have taken initiatives to increase awareness regarding vaccination to prevent occurrence of polio among the population. Public introduced beneficial immunization programs to provide vaccination to poor people, which is expected to create a highly conducive environment for growth of the Global Inactivated Polio Vaccines Market (IPV) in the near future. For instance, in September 2020, the Ghana Health Service (GHS), launched series of polio vaccination/immunization campaign to prevent spreading of the virus in high risk areas. The immunization polio vaccination campaign will use the inactivated polio vaccine (IPV) to immunize all the children born from January 2016 to June 2018 in all districts across Ghana.

Key features of the study:

This report provides in-depth analysis of the Global IPV vaccines market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global IPV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include GlaxoSmithKline Plc, Sanofi S.A., Serum Institute of India Pvt. Ltd., PT Bio Farma, and AJ Vaccines
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The IPV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global IPV vaccines market

Detailed Segmentation:

Global IPV Vaccines Market, by Vaccine Brand:
- Poliovac (Pfs/Sd)
- Shanipv
- Poliorix
- Ipol/Imovax
- Polymilex
Global IPV Vaccines Market, by Distribution Channel:
- Private
- Public
Global IPV Vaccines Market, by Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline Plc
- Sanofi S.A.
- Serum Institute of India Pvt. Ltd.
- PT Bio Farma
- AJ Vaccines

Product Code: CMI4965

1. Research Objectives and Assumptions

Research Objectives
Assumptions

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine Brand
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Vial Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Company Market Share Analysis
Import-Export Analysis
Regulatory Scenario
Pricing Analysis
COVID-19 Impact Analysis
Epidemiology
Healthcare Spending, by Country
Vaccination Rate, by Country
Manufacturing Capacities
Distributors Landscape
Investments & Funding
Competitive Snapshot
Heat Map Analysis

4. Global IPV Vaccines Market, By Vaccine Brand, 2020 - 2032 (US$ Million)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2020 - 2032
- Segment Trends
POLIOVAC (PFS/SD), 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)
SHANIPV, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)
POLIORIX, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)
IPOL/IMOVAX, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)
POLYMILEX, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)

5. Global IPV Vaccines Market, By Vaccine Type, 2020 - 2032 (US$ Million)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2020 - 2032
- Segment Trends
Combination Vaccine, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)
Single Vaccine, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)

6. Global IPV Vaccines Market, By Vial Type, 2020 - 2032 (US$ Million)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2020 - 2032
- Segment Trends
1 Dose Vial, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)
5 Dose Vial, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)
10 Dose Vial, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)

7. Global IPV Vaccines Market, By Distribution Channel, 2020 - 2032 (US$ Million)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032
- Market Y-o-Y Growth Comparison (%), 2020 - 2032
- Segment Trends
Public, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)
Private, 2020 - 2032(US$ Million)
- Introduction
- Market Size and Forecast, 2020 - 2032, (US$ Million)

8. Global IPV Vaccines Market, By Region, 2020 - 2032 (US$ Million)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Million)
- Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Million)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - Asean
  - Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Million)
  - GCC
  - Israel
  - Rest Of The Middle East
Africa
- Introduction
- Market Size and Forecast, By Vaccine Brand, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Vial Type, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (US$ Million)
- Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Million)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Competitive Snapshot
What Market Participants are Saying?
Competitive Dashboard
Company Market Share Analysis, 2025 - Global

10. Company Profiles - Global IPV Vaccines Market

Sanofi*
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Serum Institute of India Pvt. Ltd.
Bharat Biotech
Merck & Co., Inc.
GlaxoSmithKline
AJ Vaccines A/S
Panacea Biotec
Biken
Sinopharm Group Co. Ltd.
Nanolek
IMBCAMS
Sinovac Biotech
LG Chem
Beijing Minhai Biological Technology Co., Ltd.
Biological E Limited.
Section 10: Wheel of Fortune
Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

IPV Vaccines Market, by Vaccine Brand, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2032